GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	3.17B
Revenue (ttm)	2.99B
Net Income (ttm)	173.98M
Shares Out	83.51M
EPS (ttm)	2.08
PE Ratio	18.23
Forward PE	n/a
Dividend	0.75 (1.98%)
Ex-Dividend Date	Jul 18, 2024

Volume	44,749
Average Volume	27,796
Open	37.81
Previous Close	37.81
Day's Range	37.62 - 38.50
52-Week Range	24.70 - 47.30
Beta	1.03
RSI	49.02
Earnings Date	May 19, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.